Biotissue Holdings Inc.
$3.3M 20,909 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. reported $3,321,222.22 across General Payments, Research, and Ownership to 23,113 physicians and teaching hospitals across 23,378 transactions.
- $3.3M
- All-tracks total
- 23,378
- Transactions
- 23,113
- Recipients
- −$231.2K
- General Payments vs PY2023
Paratek Pharmaceuticals, Inc. reported $3,321,222.22 across all CMS Open Payments tracks (General + Research + Ownership) to 23,113 physicians and teaching hospitals in Program Year 2024 - ranking #340 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,249,632.07, averaging $143.69 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer paratek-pharmaceuticals-inc Paratek Pharmaceuticals, Inc.
$3.3M · #340/1,925 · 0.0% industry · PY2024
- TOT $3.3M
- RANK #340
- SHARE 0.0%
- TXN 23,378
- RCP 23,113
- CAT 9
- GEN $1.2M
- ΔGEN −$231.2K
- TOP1 12.4%
- PY 2024
Volume peers
Nearest volume peer: Biotissue Holdings Inc. ($3.3M)
Paratek Pharmaceuticals, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Paratek Pharmaceuticals, Inc.'s CMS-reported General Payments decreased by $231.2K (−15.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: PARATEK PHARMACEUTICALS, INC.PY2023: PARATEK PHARMACEUTICALS, INC.PY2024: Paratek Pharmaceuticals, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,480,829.62
- PY2024
- $1,249,632.07
What the Data Shows for Paratek Pharmaceuticals, Inc.
Rank #340 of 1,925 companies in CMS Open Payments for 2024 belongs to Paratek Pharmaceuticals, Inc., which reported $3,321,222.22 across 23,378 transactions to 23,113 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $142.07 per transaction and $143.69 per recipient.
The 9-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $514.1K, accounting for 41.1% of this company's General Payments and 22,441 transactions.
General Payment Breakdown by Type
Across 9 types of general payments, Paratek Pharmaceuticals, Inc.'s largest category was "Food and Beverage" at $514.1K - 41.1% of General Payments.
Paratek Pharmaceuticals, Inc. reports 9 general-payment categories - the top three are Food and Beverage (41.1%), Compensation for Services Other Than Consulting (32.7%), and Travel and Lodging (15.7%). The remaining 6 categories make up 10.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Paratek Pharmaceuticals, Inc. files across 9 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Paratek Pharmaceuticals, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $514.1K | 22,441 | 41.1% |
| Compensation for Services Other Than Consulting | $408.8K | 205 | 32.7% |
| Travel and Lodging | $196.6K | 345 | 15.7% |
| Consulting Fee | $112.4K | 43 | 9.0% |
| Space Rental or Facility Fees | $9.0K | 4 | 0.7% |
| Grant | $5.0K | 1 | 0.4% |
| Education | $3.1K | 71 | 0.2% |
| Gift | $435.36 | 1 | 0.0% |
| Entertainment | $179.39 | 2 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $407,436.58 (32.6%) of $1,249,632.07 in this company's General Payments records across 10,298 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Paratek Pharmaceuticals, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Andrew Dold
$155,391.51 across 223 reported transactions
- 2
Yoav Golan
$86,119.53 across 80 reported transactions
- 3
Warren Joseph
$76,196.43 across 66 reported transactions
- 4
David Wu
$59,150.00 across 12 reported transactions
- 5
Hector Brunet Rodriguez
$30,579.11 across 46 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Paratek Pharmaceuticals, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Paratek Pharmaceuticals, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Paratek Pharmaceuticals, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Nielsen BioSciences, Inc.
$3.3M 0 recipients
Compare payment profiles
Merit Medical Systems Inc
$3.3M 1,352 recipients
Compare payment profiles
Oyster Point Pharma, Inc.
$3.3M 19,684 recipients
Compare payment profiles
LEO Pharma Inc.
$3.3M 38,155 recipients
Compare payment profiles
Elekta, Inc.
$3.4M 610 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.